Anemia: progress in molecular mechanisms and therapies

Nature Medicine
Vijay G Sankaran, Mitchell J Weiss

Abstract

Anemia is a major source of morbidity and mortality worldwide. Here we review recent insights into how red blood cells (RBCs) are produced, the pathogenic mechanisms underlying various forms of anemia, and novel therapies derived from these findings. It is likely that these new insights, mainly arising from basic scientific studies, will contribute immensely to both the understanding of frequently debilitating forms of anemia and the ability to treat affected patients. Major worldwide diseases that are likely to benefit from new advances include the hemoglobinopathies (β-thalassemia and sickle cell disease); rare genetic disorders of RBC production; and anemias associated with chronic kidney disease, inflammation, and cancer. Promising new approaches to treatment include drugs that target recently defined pathways in RBC production, iron metabolism, and fetal globin-family gene expression, as well as gene therapies that use improved viral vectors and newly developed genome editing technologies.

References

May 4, 2004·Nature Reviews. Molecular Cell Biology·Christopher J Schofield, Peter J Ratcliffe
Feb 3, 2005·British Journal of Haematology·Osheiza AbdulmalikToshio Asakura
Mar 11, 2005·The New England Journal of Medicine·Guenter Weiss, Lawrence T Goodnough
Apr 28, 2005·Oncology·Gunnar BirgegårdSimon Van Belle
Jun 21, 2005·Nature Reviews. Cancer·Jerry L Spivak
Jul 30, 2005·Blood·Richard van Wijk, Wouter W van Solinge
Mar 28, 2008·The New England Journal of Medicine·Orah S Platt
Aug 9, 2008·The Journal of Clinical Investigation·Salima Hacein-Bey-AbinaMarina Cavazzana-Calvo
Oct 23, 2008·Lancet·Silverio PerrottaNarla Mohandas
Aug 7, 2009·Nature·Vijay G SankaranStuart H Orkin
Sep 17, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Nestor W MezaJose C Segovia
Jan 26, 2010·Nature Medicine·Huihui LiYelena Z Ginzburg
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·James E BradnerBenjamin L Ebert
Sep 17, 2010·Nature·Marina Cavazzana-CalvoPhilippe Leboulch
Nov 16, 2010·Hematology/oncology Clinics of North America·Vijay G Sankaran, David G Nathan
Nov 26, 2010·The Journal of Clinical Investigation·Sara GardenghiStefano Rivella
Dec 7, 2010·Lancet·David C ReesMark T Gladwin
Jan 6, 2011·Proceedings of the National Academy of Sciences of the United States of America·Vijay G SankaranHarvey F Lodish
Mar 9, 2011·The Journal of Clinical Investigation·Jung-Eun JangPaul S Frenette
Mar 30, 2011·Nature Reviews. Genetics·Luigi Naldini
Sep 2, 2011·The New England Journal of Medicine·Vijay G SankaranM A Bender
Nov 2, 2011·Proceedings of the National Academy of Sciences of the United States of America·Andrew D CampbellJames Douglas Engel

❮ Previous
Next ❯

Citations

Jan 26, 2016·International Journal of Molecular Sciences·Raffaella Gozzelino, Paolo Arosio
Sep 12, 2015·Expert Opinion on Investigational Drugs·Ugo TestaPelosi Elvira
Jan 15, 2016·Molecular Therapy : the Journal of the American Society of Gene Therapy·Versha PrakashRafael J Yáñez-Muñoz
Feb 6, 2016·British Journal of Haematology·Satish K NandakumarVijay G Sankaran
Nov 6, 2015·American Journal of Hematology·Deborah Rund
Dec 15, 2015·Molecular Therapy. Methods & Clinical Development·Tamara I PestinaDerek A Persons
Mar 11, 2016·Annals of the New York Academy of Sciences·Anindita Basak, Vijay G Sankaran
Aug 1, 2015·Blood·Marjorie Brand
Mar 29, 2016·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·Dong-Zhi LiYan-Mei Ou
Oct 3, 2015·Blood·Jeremie Heath Estepp
May 6, 2015·The Journal of Clinical Investigation·Anindita BasakVijay G Sankaran
Apr 29, 2016·Expert Opinion on Investigational Drugs·Holger Schmid, Wolfgang Jelkmann
Jun 28, 2016·Experimental Hematology·Ah Ram Kim, Vijay G Sankaran
Aug 19, 2016·Expert Opinion on Emerging Drugs·Jolanta Malyszko, Jacek S Malyszko
Oct 27, 2016·Stem Cells·Adam L MacLeanMichael P H Stumpf
Oct 30, 2016·American Journal of Medical Genetics. Part C, Seminars in Medical Genetics·Leif S LudwigVijay G Sankaran
Jun 8, 2017·Hematology·Naouel Ben SalahAli T Taher
Jan 18, 2017·Proceedings of the National Academy of Sciences of the United States of America·Quan LiWilliam A Eaton
Jul 4, 2017·Metallomics : Integrated Biometal Science·Elena GammellaStefania Recalcati
Jun 2, 2017·American Journal of Hematology·Claudia FioriniVijay G Sankaran
Feb 1, 2018·Journal of Pediatric Gastroenterology and Nutrition·Erasmo MieleAnnamaria Staiano
Jan 11, 2018·International Journal of Molecular Sciences·Joseph SleimanAli T Taher
Feb 2, 2018·Current Opinion in Hematology·Andrea A Perreault, Bryan J Venters
Sep 19, 2017·Biological Trace Element Research·Yujie NingMikko Lammi
Sep 21, 2017·Drug Testing and Analysis·Christian ReichelMario Thevis
Dec 2, 2017·Drug Testing and Analysis·Christian ReichelMario Thevis
Jul 25, 2017·American Journal of Hematology·Alawi H HabaraMartin H Steinberg
Sep 12, 2018·Drug Testing and Analysis·Christian ReichelMario Thevis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anemia

Anemia develops when your blood lacks enough healthy red blood cells. Anemia of inflammation (AI, also called anemia of chronic disease) is a common, typically normocytic, normochromic anemia that is caused by an underlying inflammatory disease. Here is the latest research on anemia.

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Related Papers

Current Opinion in Pediatrics
Javid Gaziev, Guido Lucarelli
JAMA : the Journal of the American Medical Association
G P Rodgers
Médecine tropicale : revue du Corps de santé colonial
M de Montalembert
© 2022 Meta ULC. All rights reserved